Navigation Links
23ème congrès européen sur l'Hypertension et la Protection Cardiovasculaire
Date:6/25/2013

n)[9]

Différentes bithérapies antihypertensives peuvent être utilisées dans la pratique clinique. Cependant, des études ont mis en évidence une efficacité particulière pour les traitements associant un diurétique avec un inhibiteur de l'enzyme de conversion (IEC), un antagoniste des récepteurs de l'angiotensine (ARA II), ou un inhibiteur calcique. Des études récentes à grande échelle ont aussi mis en évidence une efficacité particulière pour l'association d'un IEC et d'un inhibiteur calcique. L'association d'un antagoniste des récepteurs de l'angiotensine et d'un inhibiteur calcique semble aussi être rationnelle et efficace.

Chez au moins 15 à 20% des patients hypertendus, la pression artérielle n'est pas contrôlée par une bithérapie. Lorsque trois médicaments sont nécessaires, l'association la plus optimale semble être un bloqueur du système rénine-angiotensine associé à un inhibiteur calcique et à un diurétique à doses efficaces.[9]

A propos de Daiichi Sankyo

Le Groupe Daiichi Sankyo s'est donné pour mission de créer et fournir des produits pharmaceutiques innovants pour répondre aux divers besoins médicaux non satisfaits des patients dans les marchés matures et émergents. Tout en maintenant son portefeuille de médicaments commercialisés pour traiter l'hypertension, l'hyperlipidémie, et les maladies infectieuses, le Groupe se concentre aussi sur le développement de traitements pour les maladies thrombotiques, et sur la découverte de traitements originaux dans les domaines de l'oncologie et des pathologies cardiovasculaires et métaboliques. Par ailleurs, le Groupe Daiichi Sankyo a créé un "Modèle Économique Hybride" afin de r&#
'/>"/>

SOURCE Daiichi Sankyo Europe GmbH
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
2. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
3. Global Leaders in Advanced Biofuels Industry Urge Congressional Leaders to Extend Critical Tax Provisions
4. Nation Must Invest in Biomedical Research/Health Workforce, AAHC President Tells Congress
5. PharmAthene Presents Update on SparVax™ rPA Anthrax Vaccine Program at the 2012 World Vaccine Congress
6. Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London
7. ETEX Corporation to present at the 9th World Biomaterial Congress
8. Discovery Labs to Present AFECTAIR® Data at European Congress on Pediatric and Neonatal Ventilation
9. PROLOR Biotech Announces Presentation of Data on Its Long-Acting Clotting Factors at World Federation of Hemophilia World Congress
10. The Legends that Contributed to Silicon Valleys Eminence Assemble for Frost & Sullivans Growth, Innovation and Leadership 2012 Congress
11. BIOCOM Announces Endorsement in 52nd Congressional District Race
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Charm Sciences is pleased to announce that ... Aflatoxin M1 in raw commingled milk is the first ... The peer reviewed report of the validation by Technology ... and Fisheries Research (ILVO-T&V) has been published by the ... most toxic aflatoxin and a known carcinogen, can be ...
(Date:12/19/2014)... , Dec. 19, 2014 Bina Technologies, Inc. ... announced today that they have been acquired by Roche ... is a privately held company that provides a big ... generation sequencing (NGS) data for the academic and translational ... Sequencing Unit, and will continue to focus on development ...
(Date:12/19/2014)... December 18, 2014 Today, ... its pilot production facility and future company headquarters ... produce innovative new materials that safely and effectively ... only because of its historic, strong support for ... to attract leading edge, technology-based companies such as ...
(Date:12/19/2014)... iLab Solutions, the global leader in ... Bryant as the new Director of Institutional Implementations and ... These two new leadership positions were created to support ... that iLab continues to meet the needs of its ... iLab has been deployed at over 450 core facilities ...
Breaking Biology Technology:Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 4iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2
... Ga., Jan. 10, 2012  MiMedx Group, Inc. (OTCBB: ... patent protected regenerative biomaterials and bioimplants processed from ... received the certification for the Company,s proprietary CollaFix™ ... Mesh CD, which is a Class III product ...
... 10, 2012 iBio, Inc. (NYSE AMEX: IBIO) announced ... units at $0.65 per unit for gross proceeds of approximately ... stock and 0.75 of a warrant to purchase one share ... of $0.88 per share, will be exercisable beginning one year ...
... BOTHELL, Wash., Jan. 10, 2012   BioLife Solutions Inc. ... hypothermic storage and cryopreservation freeze media ... the fourth quarter and full calendar year 2011. Highlights include: ... Preliminary fourth quarter revenue of $809,000, up 13% over the ...
Cached Biology Technology:MiMedx Group, Inc. Receives CE Certification for Its CollaFix™ Surgical Mesh CD 2iBio, Inc. Prices $10 Million Public Offering 2iBio, Inc. Prices $10 Million Public Offering 3iBio, Inc. Prices $10 Million Public Offering 4BioLife Solutions 2011 Revenue Up 33% 2BioLife Solutions 2011 Revenue Up 33% 3
(Date:12/17/2014)... Dec. 15, 2014  HITLAB SM announced ... (GCP) audit to confirm its adherence to current ... accomplishment enables HITLAB to conduct regulated smart device ... principles for patient safety and research quality. ... access, quality, and delivery with innovative technology," said ...
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ...  report to their offering. One ... in technology. With continuous advances in technology, it ... latest standard that meets the needs and expectations ...
(Date:12/10/2014)... 9, 2014  Valencell, a leader in performance biometric ... staggering demand from its licensees for highly accurate, clinically ... not solely coming from fitness and health sectors, but ... "A wearable is only as useful as the biometric ... ultimate driver in long-term mass consumer adoption of wearable ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... inside the nuptial gift that a potential suitor brings to ... the whole package, white silk wrappings and all, that can ... Mariana Trillo, Valentina Melo-Gonzlez and Mara Jos Albo of the ... out the first study to look at the role of ...
... matter microstructure, the communication pathways of the brain, continues ... in white matter microstructure to specific cognitive abilities in ... not include individuals from the entire life span or ... knowledge gap prompted a new study published this week ...
... Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is pleased ... AIDS treatment and prevention programs in six districts ... for International Development (USAID) and the U.S. President,s ... services offered through EGPAF,s Strengthening Clinical Services (SCS) ...
Cached Biology News:White silk wrappings key to female spider's heart 2Your brain is fine-tuning its wiring throughout your life 2Lesotho takes new steps toward HIV/AIDS elimination 2
Any form, any size, any number of mutageneses. ExonBio provides the best service with double sequecing to make sure the success of the mutagenesis....
Loading Buffer...
Request Info...
Request Info...
Biology Products: